KMT2D and lung carcinoma: TFB1M is a mitochondrial transcription specificity factor that maintains homeostasis of oxidative phosphorylation and glycolysis [127, 128], pathways that have been shown to be dysregulated in KMT2D-deficient lung cancers [117], epithelial cells, and Kabuki Syndrome patients [118].